Sichuan Hexie Shuangma Co Ltd
Sichuan Hexie Shuangma Co., Ltd. engages in the manufacture and sale building material products in China. It offers cement, commercial clinker, and aggregates used for infrastructure, industrial park construction, municipal livelihood projects, commercial housing development, urban renewal, and rural revitalization. The company is also involved in biopharmaceutical research and development and production business; and private equity investment fund management business. In addition, the company engages in peptide API research and development, and production; peptide contract customization; customized research and development, and production business; and beauty peptide research and development, and production business. Further, it offers semaglutide, liraglutide, and tilpotide targeting major chronic diseases; and invest in manufacturing and new energy industries, including photovoltaics, chip design and manufacturing, consumer electronics, intelligent equipment, industrial automation, new energy, autonomous driving, and semiconductor equipment. The company was formerly known as SICHUAN SHUANGMA CEMENT CO., Ltd and changed its name to Sichuan Hexie Shuangma Co., Ltd. in February 2022. Sichuan Hexie Shuangma Co., Ltd. was founded in 1998 and is based in Chengdu, China.
If you'd bought from year…
Same habit, different start year. Each row shows what a constant habit's worth of 000935-SZ would be worth today, had you started buying at that point in the asset's history.
| Started | $6/day$6/day coffee | $42/wk$42/week coffee |
|---|---|---|
| Year 1 (1999) — listing | $156,985 4.0× | $226,506 3.9× |
| Year 6 (2004) | $122,650 3.7× | $178,257 3.7× |
| Year 11 (2009) | $71,010 2.8× | $104,970 2.8× |
| Year 16 (2014) | $43,664 2.4× | $64,589 2.4× |
| Year 21 (2019) | $19,463 1.8× | $28,823 1.8× |
| Year 26 (2024) | $6,019 1.7× | $9,042 1.7× |
Repeated investment, no fees, dividends reinvested. $6/day coffee = $180 / month equivalent.
Popular scenarios with 000935
For illustration only — not investment advice. Past performance is not indicative of future results.